Pricing

Log inSign up

DURECT

1 follower

‌

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.

Industries

Pharmaceutical

Headquarters

Cupertino, United States

Employees

51-200

Links

Org chart

James E. Brown
President & CEO
Collapse
NS
Norman L. Sussman
Chief Medical Officer
JJ
Judy Joice
SVP, Operations & Corporate Quality Assurance
DE
David J. Ellis
VP, Clinical Development
SH
Steve Helmer
Vice President, Chief Patent Counsel
WL
Weiqi Lin
EVP, Research & Development & Principal Scientist
CC
Charlie Claycomb
Executive Director Information Technology
SA
Susan Autio
Exe. Director Engineering Manufacturing Development & Clinical Packaging
JG
John Gibson
VP Birmingham Operations
Pete Garcia
Member Board Of Directors
TP
Timothy M. Papp
CFO

Board & advisors

TB
Terrence F. Blaschke
Director
GF
Gail M. Farfel
Director
Judith J. Robertson
Director
PG
Peter Garcia
Director
GM
Gail J. Maderis
Chair of the Board

Teams

AM
DE
JJ
+5

Leadership Team

9 people · 0 jobs

AM
DE
JW
WL
+5

Scientific Research and Development

9 people · 0 jobs

GF
PG
+4

Director Team

8 people · 0 jobs

BK
JD
JS

Manufacturing and Production

3 people · 0 jobs

VN

Operations and Support

3 people · 0 jobs

GH
JJ

Quality Assurance Team

2 people · 0 jobs

Offices

Similar companies

Xeris Pharmaceuticals

2 followers

Cosette Pharmaceuticals

1 follower

Bristol-Myers Squibb

250 followers

NYU Langone Health

24 followers

West Pharmaceutical Services

8 followers

Curia Global

6 followers

AbbVie

270 followers

Navitus Health

3 followers

Corcept Therapeutics

4 followers

Catalyst Pharmaceuticals

2 followers

Arthritis Knee Pain Centers

2 followers

Explore companies